| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 27, 2025 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 27, 2025 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/30/2021 | $4.34 | Buy | Roth Capital |
4 - Research Solutions, Inc. (0001386301) (Issuer)
4 - Research Solutions, Inc. (0001386301) (Issuer)
4 - Research Solutions, Inc. (0001386301) (Issuer)
New Rankings Method Addresses Longstanding Limitation In Traditional Academic Evaluation Methods, Providing New Insight Into Research Impact & Veracity HENDERSON, Nev., Oct. 8, 2025 /PRNewswire/ -- Research Solutions (NASDAQ:RSSS), a leading provider of AI-powered scientific research tools, today announced the launch of Scite Rankings, the first global research ranking system built on artificial intelligence-driven citation analysis. Unlike traditional rankings that reward citation volume alone, Scite Rankings evaluates how research is cited, whether work is supported, contras
Reports 36% YoY Platform Revenue Increase, ARR of $20.9 Million and Record Fiscal Year Net Income and Adjusted EBITDA HENDERSON, Nev., Sept. 18, 2025 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, reported financial results for its fourth quarter and full fiscal year ended June 30, 2025. Fiscal Fourth Quarter 2025 Summary (compared to prior-year quarter) Platform revenue up 21% to $5.2 million. Annual Recurring Revenue ("ARR") up 20% to $20.9 million, which includes approximately $14.2 million of B2B recurring revenue
Solution Enables Corporate Researchers To Safely Use Generative AI Tools With Journal Articles Through Integrated Rights Management And Publisher Partnerships HENDERSON, Nev., Sept. 11, 2025 /PRNewswire/ -- Research Solutions (NASDAQ:RSSS), a leading provider of AI-powered scientific research tools, announces the commercial launch of its AI Rights add-on for Article Galaxy, enabling corporate researchers to compliantly use generative AI tools with scientific journal content at scale. The solution addresses a critical compliance gap affecting 76% of researchers who now use AI tools in their workflows but lack clear guidance on copyright permissions for scientific content analysis.
Roth Capital initiated coverage of Research Solutions with a rating of Buy and set a new price target of $4.35
Maxim Group initiated coverage of Research Solutions with a rating of Buy and set a new price target of $6.00
DEFA14A - Research Solutions, Inc. (0001386301) (Filer)
DEF 14A - Research Solutions, Inc. (0001386301) (Filer)
10-K - Research Solutions, Inc. (0001386301) (Filer)
SaaS Executive with Track Record of Accelerating Growth HENDERSON, Nev., Nov. 19, 2024 /PRNewswire/ -- Research Solutions (NASDAQ:RSSS), a pioneer in scientific content delivery, today announced the appointment of Sefton Cohen as Chief Revenue Officer. Cohen brings over two decades of experience scaling high-growth SaaS companies and will play a pivotal role in accelerating Research Solutions' transformation from a scientific content provider to a comprehensive AI-enabled research intelligence platform. "Sefton's proven track record of driving triple-digit growth in the SaaS i
Transforms Search and Discovery Solutions for Researchers by Delivering Breakthrough AI Technology Adds $3.6 Million in Annualized Software Subscription Revenue HENDERSON, Nev., Nov. 27, 2023 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), a trusted partner providing cloud-based workflow solutions to accelerate research for R&D-driven organizations, today announced their acquisition of scite, an award-winning search and discovery platform that leverages AI to increase the discoverability and evaluation of research. RSSS) acquires scite, an award-winning search and discovery platform." alt="Research Solutions, Inc.
Reports 36% YoY Platform Revenue Increase, ARR of $20.9 Million and Record Fiscal Year Net Income and Adjusted EBITDA HENDERSON, Nev., Sept. 18, 2025 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, reported financial results for its fourth quarter and full fiscal year ended June 30, 2025. Fiscal Fourth Quarter 2025 Summary (compared to prior-year quarter) Platform revenue up 21% to $5.2 million. Annual Recurring Revenue ("ARR") up 20% to $20.9 million, which includes approximately $14.2 million of B2B recurring revenue
HENDERSON, Nev., Sept. 8, 2025 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, will hold a conference call to discuss its financial results for the fourth quarter and full year fiscal 2025 ended June 30, 2025, on Thursday, September 18, 2025, at 5:00 p.m. ET. A press release containing the company's financial results will be issued following the market close and prior to the call. Research Solutions President and CEO Roy W. Olivier and CFO Bill Nurthen will host the conference call, followed by a question and answer pe
Expects Record Fiscal Year Revenue, Net Income, Adjusted EBITDA and Cash Flow HENDERSON, Nev., Aug. 19, 2025 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, announced selected preliminary financial results for its fiscal fourth quarter and fiscal year ended June 30, 2025. Based on preliminary unaudited information, Research Solutions expects the following results for its fiscal fourth quarter 2025: Platform revenue expected to be up 21% from the prior-year quarter to approximately $5.2 million; Annual recurring revenue
SC 13D/A - Research Solutions, Inc. (0001386301) (Subject)
SC 13D/A - Research Solutions, Inc. (0001386301) (Subject)
SC 13D/A - Research Solutions, Inc. (0001386301) (Subject)